Related Experiment Video
Updated: May 31, 2025

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens
Giedrė Valdonė Sakalauskienė1, Lina Malcienė1, Edgaras Stankevičius1
1Institute of Physiology and Pharmacology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Abstract:
Multidrug antimicrobial resistance (AMR) represents a formidable challenge in the therapy of infectious diseases, triggered by the particularly concerning gram-negative Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. (ESKAPE) pathogens. Designated as a "priority" in 2017, these bacteria continue to pose a significant threat in 2024, particularly during the worldwide SARS-CoV-2 pandemic, where coinfections with ESKAPE members contributed to worsened patient outcomes. The declining effectiveness of current treatments against these pathogens has led to an increased disease burden and an increase in mortality rates globally. This review explores the sophisticated mechanisms driving AMR in gram-negative ESKAPE bacteria, focusing on Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Enterobacter spp. Key bacterial mechanisms contributing to resistance include limitations in drug uptake, production of antibiotic-degrading enzymes, alterations in drug target sites, and enhanced drug efflux systems. Comprehending these pathways is vital for formulating innovative therapeutic strategies and tackling the ongoing threat posed by these resistant pathogens.
Insights
Multidrug antimicrobial resistance (AMR) in gram-negative ESKAPE pathogens is a major global health threat. Understanding resistance mechanisms like drug efflux and target modification is crucial for developing new treatments.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Multidrug antimicrobial resistance (AMR) poses a significant challenge in treating infections, especially from gram-negative ESKAPE pathogens.
- ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.) are a priority due to rising resistance.
- The COVID-19 pandemic exacerbated the threat, with coinfections leading to poorer patient outcomes and increased mortality.
Purpose of the Study:
- To review the sophisticated mechanisms driving AMR in gram-negative ESKAPE bacteria.
- To focus on Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Enterobacter spp.
- To highlight the importance of understanding these mechanisms for developing new therapies.
Main Methods:
- Literature review of scientific articles and reports on antimicrobial resistance in ESKAPE pathogens.
- Analysis of key bacterial resistance mechanisms.
- Synthesis of information on drug uptake, enzyme degradation, target modification, and efflux systems.
Main Results:
- Gram-negative ESKAPE bacteria employ diverse strategies to resist antibiotics.
- Mechanisms include reduced drug permeability, antibiotic-inactivating enzymes, altered drug targets, and active efflux pumps.
- These mechanisms contribute to the declining effectiveness of current treatments.
Conclusions:
- A comprehensive understanding of AMR mechanisms in gram-negative ESKAPE pathogens is essential.
- This knowledge is vital for designing novel therapeutic strategies.
- Addressing AMR in these priority pathogens is critical to reduce the global disease burden and mortality.
More Related Videos
Related Concept Videos
Antibiotic Selection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Genomic DNA in Prokaryotes
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...

